Clinical Trial Update: To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial assessing the pharmacokinetics of tiotropium in subjects with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: COPD | Phase 1, Phase 2 | Status: COMPLETED